Genesystem

진시스템 · 363250

Health Care Medical Devices · KOSDAQ

Small-cap

Market cap US$23M (₩31.7B)

Overview

Genesystem develops and makes molecular diagnostic tools, compact devices, biochips, test kits, and reagents that identify diseases by detecting genetic material, including at the point of care rather than in a central lab.

Its products are designed for ease of use, with reagents built directly into the biochip, and are aimed at clinical and diagnostic customers. Listed on KOSDAQ, Korea's tech-focused small-cap board, the company generates a meaningful share of its revenue from exports. Its core platform supports a range of respiratory-disease test content, which it continues to expand for global distribution.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$276.3K
▼ −68.4% YoY
Operating profit · FY2025
−US$7M
Loss narrowed
Net income · FY2025
−US$10.6M
Loss widened

Revenue

  • FY2023US$650K
  • FY2024US$875.2K
  • FY2025US$276.3K

Operating profit

  • FY2023−US$6.9M
  • FY2024−US$7.3M
  • FY2025−US$7M

Net income

  • FY2023−US$5.8M
  • FY2024−US$6.9M
  • FY2025−US$10.6M

Key ratios (FY2025)

ROE
-189.3%
Debt/Eq
85.8%
Op. margin
-2541.0%
Net margin
-3846.6%
Rev. YoY
▼ −68.4%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.